Pacholczyk T, Blakely R D, Amara S G
Section of Molecular Neurobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06510.
Nature. 1991 Mar 28;350(6316):350-4. doi: 10.1038/350350a0.
At most synapses, chemical signalling is terminated by a rapid reaccumulation of neurotransmitter into presynaptic terminals. Uptake systems for the biogenic amines are the initial site of action for therapeutic antidepressants and drugs such as cocaine and the amphetamines. We have isolated a complementary DNA clone encoding a human noradrenaline transporter. The cDNA sequence predicts a protein of 617 amino acids, with 12-13 highly hydrophobic regions compatible with membrane-spanning domains. Expression of the cDNA clone in transfected HeLa cells indicates that noradrenaline transport activity is sodium-dependent and sensitive to selective noradrenaline transport inhibitors. Transporter RNA is localized to the brainstem and the adrenal gland. The predicted protein sequence demonstrates significant amino-acid identity with the Na+/gamma-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins. Analysis of its structure and function may lead to structure-based drug design for the treatment of human depression and could help determine whether transporter abnormalities underlie affective disorders.
在大多数突触中,化学信号传导通过神经递质快速重新积累到突触前终末而终止。生物胺的摄取系统是治疗性抗抑郁药以及可卡因和苯丙胺等药物的初始作用位点。我们分离出了一个编码人去甲肾上腺素转运体的互补DNA克隆。该cDNA序列预测出一个由617个氨基酸组成的蛋白质,有12 - 13个与跨膜结构域相符的高度疏水区域。该cDNA克隆在转染的HeLa细胞中的表达表明,去甲肾上腺素转运活性依赖于钠,且对选择性去甲肾上腺素转运抑制剂敏感。转运体RNA定位于脑干和肾上腺。预测的蛋白质序列与Na⁺/γ-氨基丁酸转运体有显著的氨基酸同一性,从而确定了神经递质转运体蛋白的一个新基因家族。对其结构和功能的分析可能会导致基于结构的药物设计来治疗人类抑郁症,并有助于确定转运体异常是否是情感障碍的基础。